In a community-based, cluster-randomized study, scaling up HIV testing and offering antiretroviral therapy regardless of CD4 count to those infected did not affect HIV incidence. Poor linkage to care was likely the limiting factor.
Achieving near-universal antiretroviral therapy (ART) coverage has been proposed to reduce HIV transmission and is the basis of the UNAIDS 90-90-90 goals. Of four population-based studies investigating if this hypothesis is true, investigators have now published one, ANRS 12249, a cluster-randomized trial in 22 communities in rural KwaZulu-Natal, South Africa, where the estimated HIV prevalence is 30%. Clusters of residents aged 16 or older were randomized to control (ART initiation according to national guidelines) or intervention (ART initiation regardless of CD4 count).
Investigators contacted 26,518 individuals (93% of those eligible), of whom 88% had HIV status ascertained and 17,808 (67%) were HIV negative on initial testing; of these,…
Reviewing Author
DisclosuresGrant/Research SupportNIH/National Institute of Allergy and Infectious Diseases; NIH/National Institute on Drug Abuse
Editorial BoardsJAIDS: Journal of Acquired Immune Deficiency Syndromes; Vaccines
Leadership Positions in Professional SocietiesInternational Antiviral Society–USA (Board of Directors); Infectious Diseases Society of America (Past President)
DisclosuresGrant/Research SupportNIH/National Institute of Allergy and Infectious Diseases; NIH/National Institute on Drug Abuse
Editorial BoardsJAIDS: Journal of Acquired Immune Deficiency Syndromes; Vaccines
Leadership Positions in Professional SocietiesInternational Antiviral Society–USA (Board of Directors); Infectious Diseases Society of America (Past President)